Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Truist Securities analyst Jailendra Singh reiterated a Hold rating and $32.00 price target on Hims and Hers (NYSE: HIMS).

The analyst comments "Details on GLP-1 Transaction Trends. On a per-day basis, our Truist Card Data indicates GLP-1 billings in September were down 16% M/M (vs August up 1% M/M). On a per-day basis, September GLP-1 transactions were down 11% M/M (vs August down 9% M/ M on a comparable basis). On a transactions-weighted basis, average duration was 1.12 months in September, down from 1.26 months in August. We would note that branded GLP-1 membership counts for the most recent month should be viewed as provisional, as certain transactions cannot be definitively classified as branded GLP-1 related until the subsequent month's card data becomes available, which may include the associated prescription fill and drug cost. As an example, August's reported decline in GLP-1 transactions improved from approximately 9% M/M to 6% M/M following receipt of September Truist Card Data. We expect September's membership figures to similarly improve as October Truist Card Data becomes available. The same dynamic applies to the branded GLP-1 analysis discussed below. For all of 3Q26, on a per-day basis, our Truist Card Data indicated GLP-1 billings were up 22% Q/Q and GLP-1 transactions were up 21% Q/Q. On a transaction-weighted basis, average duration was 1.20 months in 3Q26, down from 1.34 months in 2Q26."

For an analyst ratings summary and ratings history on Hims and Hers click here. For more ratings news on Hims and Hers click here.

Shares of Hims and Hers closed at $29.54 yesterday.

You May Also Be Interested In

• HIMS jumps 7% on peptide tailwind but Citi sees 17% downside from here
• GTCR and Elliott nearing deal for CCC Intelligent Solutions - Bloomberg
• CrowdStrike urges stockholders to reject Tutanota mini-tender offer